| 期 |
栏目 |
标题 |
文件 |
| 卷 78, 编号 2 (2003) |
Editorial |
Esomeprasol in the treatment of duodenal ulcer under various regimens of antihelicobacter therapy |
|
| 卷 78, 编号 11 (2003) |
Editorial |
Results of an open multicenter study of theefficiency of one-week antihelicobacter therapy using omeprazole, clarithromycin, and amoxycillin in patients withduodenal peptic ulcer |
|
| 卷 78, 编号 11 (2003) |
Editorial |
Herpesvirus es-ophagitis |
|
| 卷 79, 编号 2 (2004) |
Editorial |
Comparative efficacy of different therapeutic schemes in gastropathies provoked by nonsteroid anti-inflammatory drugs |
|
| 卷 79, 编号 2 (2004) |
Editorial |
Optimal diagnosis and therapy of gastroesophageal reflux disease |
|
| 卷 80, 编号 2 (2008) |
Editorial |
Features of combined (hbv/hcv-infection) viral lesion of the liver |
|
| 卷 83, 编号 6 (2011) |
Editorial |
Bronchial asthma and gastroesophageal reflux disease: view of the clinician and pathophysiologist |
|
| 卷 83, 编号 8 (2011) |
Editorial |
Helicobacter pylori: what schemes of eradication are essential today? |
|
| 卷 84, 编号 2 (2012) |
Editorial |
Autoimmune pancreatitis: current status |
|
| 卷 85, 编号 2 (2013) |
Editorial |
Difficulties and errors in the management tactics of patients with chronic pancreatitis |
|
| 卷 85, 编号 4 (2013) |
Editorial |
Current recommendations for the diagnosis of chronic pancreatitis in general clinical practice |
|
| 卷 85, 编号 8 (2013) |
Editorial |
Teaching therapeutic disciplines: vectors of modernization |
|
| 卷 85, 编号 8 (2013) |
Editorial |
Irritable bowel syndrome: The present view of the problem |
|
| 卷 86, 编号 2 (2014) |
Editorial |
Evolution of clinical ideas about Zollinger-Ellison syndrome |
|
| 卷 86, 编号 3 (2014) |
Editorial |
Eradication therapy for Helicobacter pylori infection: Review of world trends |
|
| 卷 86, 编号 8 (2014) |
Editorial |
New approaches to diagnosing and treating Crohn's disease |
|
| 卷 86, 编号 4 (2014) |
Editorial |
Alcoholic liver disease: State-of-the-art |
|
| 卷 86, 编号 8 (2014) |
Editorial |
Role of psychological correction in the combination treatment of patients with gastroesophageal reflux disease |
|
| 卷 86, 编号 8 (2014) |
Editorial |
Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases |
|
| 卷 86, 编号 12 (2014) |
Editorial |
Prospects for improving the management tactics for patients with gastroesophageal reflux disease complicated by Barrett's esophagus |
|
| 卷 87, 编号 2 (2015) |
Editorial |
Pharmacotherapy for irritable bowel syndrome in the context of evidence-based medicine |
|
| 卷 87, 编号 3 (2015) |
Editorial |
An immune response and an alveolar macrophage phenotype in asthma, gastroesophageal reflux disease and their concurrence |
|
| 卷 87, 编号 4 (2015) |
Editorial |
Evolution of ideas on microscopic colitis |
|
| 卷 87, 编号 8 (2015) |
Editorial |
Helicobacter pylori infection and extragastroduodenal diseases |
|
| 卷 87, 编号 12 (2015) |
Editorial |
Specific features of the enteric microbiota composition in patients with alcoholic liver cirrhosis |
|
| 卷 88, 编号 2 (2016) |
Editorial |
European Registry on the management of Helicobacter pylori infection (Hp-EuReg protocol): The first results of Russian centers |
(Rus)
|
| 卷 88, 编号 2 (2016) |
Editorial |
Nutritional status in patients with chronic pancreatitis |
(Rus)
|
| 卷 88, 编号 4 (2016) |
Editorial |
The efficiency and safety of anti-Helicobacter pylori therapy in patients with concomitant chronic hepatitis C |
(Rus)
|
| 卷 89, 编号 2 (2017) |
Editorial |
Ultrasound elastography of the liver for assessing the risk of complications of its cirrhosis of different etiologies |
(Rus)
|
| 卷 89, 编号 2 (2017) |
Editorial |
Possibilities of pH impedance and high-resolution manometry in managing patients with refractory gastroesophageal reflux disease |
(Rus)
|
| 卷 89, 编号 2 (2017) |
Editorial |
Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice |
(Rus)
|
| 卷 89, 编号 3 (2017) |
Editorial |
All-Russian Consensus on Diagnosis and Treatment of Celiac Disease in Children and Adults |
(Rus)
|
| 卷 89, 编号 2 (2017) |
Editorial |
The Russian consensus on the diagnosis and treatment of chronic pancreatitis |
|
| 卷 89, 编号 8 (2017) |
Editorial |
Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy |
(Rus)
|
| 卷 89, 编号 8 (2017) |
Editorial |
The Russian consensus on the diagnosis and treatment of chronic pancreatitis: Enzyme replacement therapy |
(Rus)
|
| 卷 90, 编号 8 (2018) |
Editorial |
Modern achievements in the diagnosis and treatment of the refractory gastroesophageal reflux disease |
(Rus)
|
| 卷 90, 编号 8 (2018) |
Editorial |
Russian consensus on exoand endocrine pancreatic insufficiency after surgical treatment |
(Rus)
|
| 卷 90, 编号 8 (2018) |
Editorial |
Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study |
(Rus)
|
| 卷 90, 编号 5 (2018) |
Editorial |
High resolution manometry and new classification of esophageal motility disorders |
(Rus)
|
| 卷 90, 编号 8 (2018) |
Editorial |
Effectiveness of mebeverine in patients with post-cholecystectomy gastrointestinal spasm: results of prospective observational program “odyssey” |
(Rus)
|
| 卷 90, 编号 8 (2018) |
Editorial |
Pharmacotherapy of chronic pancreatitis in terms of current clinical recommendations |
(Rus)
|
| 卷 90, 编号 2 (2018) |
Editorial |
Features of the functional activity of macrophage link of immunity with gastroesophageal reflux disease depending on the type of reluctate: in vitro model |
(Rus)
|
| 卷 90, 编号 2 (2018) |
Editorial |
Evropeyskiy registr Helicobacter pylori (Hp-EuReg): analiz dannykh 2360 bol'nykh, poluchavshikh terapiyu pervoy linii v Rossii |
(Rus)
|
| 卷 90, 编号 2 (2018) |
Editorial |
The cardiovascular system in patients with functional and inflammatory bowel diseases |
(Rus)
|
| 卷 90, 编号 2 (2018) |
Editorial |
Cellular and molecular mechanisms of inflammation of esophageal mucosa under different clinical course of gastroesophageal reflux disease and its complications |
(Rus)
|
| 卷 91, 编号 2 (2019) |
Editorial |
European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years |
(Rus)
|
| 卷 91, 编号 2 (2019) |
Editorial |
Phenotype of obesity and gastroesophageal reflux disease in the context of comorbidity in patients with cardiovascular diseases |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
Efficacy of H. pylori eradication depending on genetic polymorphism of CYP2C19, MDR1 and IL-1β |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
Methanobrevibacter smithii in irritable bowel syndrome: a clinical and molecular study |
(Rus)
|
| 卷 92, 编号 1 (2020) |
Editorial |
The effectiveness of pancreatic enzyme replacement therapy using microencapsulated pancreatin preparations in the correction of nutritional status in patients with chronic pancreatitis: a prospective observational study |
(Rus)
|
